ASPIRIN WITH AN ADRENERGIC OR A CALCIUM-CHANNEL-BLOCKING AGENT AS NEW COMBINATION THERAPY FOR ARTERIAL THROMBOSIS
- 9 February 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 325 (8424) , 351-352
- https://doi.org/10.1016/s0140-6736(85)91133-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Platelet aggregation studies in whole human bloodThrombosis Research, 1983
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINKThe Lancet, 1982
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Effect of propranolol on platelet functionBlood, 1977